Prevalence of Tuberculosis, Drug Susceptibility Testing, and Genotyping of Mycobacterial Isolates from Pulmonary Tuberculosis Patients in Dessie, Ethiopia

Table 2

The risk of any resistance to INH by gender, HIV status, previous anti-TB treatment, and age group assessed using the Chi square test.

Variable	Any resistance to INH		OR (95% CI)	value
	Susceptible (%)	Resistant (%)
Sex			0.67 (0.22–1.94)	0.47
Male	54 (84.4)	10 (15.6)
Female	48 (88.8)	6 (11.2)
HIV status			0.82 (0.17–4.02)	0.81
Positive	15 (88.2)	2 (11.8)
Negative	87 (86.1)	14 (13.9)
Previous history of anti-TB treatment			0.36 (0.10–1.32)	0.11
Yes	11 (73.3)	4 (26.7)
No	91 (88.3)	12 (11.7)
Age				0.58
10–15	4 (100)	0 (0)
16–30	67 (90.5)	7 (9.4)
31–45	22 (70.9)	9 (29.0)
>45	9 (100)	0 (0)
Total	97 (82.2)	21 (17.8)